A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan

Journal of Experimental Medicine

Volumn 200, Issue 7, 2004, Pages 895-904

  Amprey, Joseph L ^a,b   Im, Jin S ^b   Turco, Salvatore J ^c   Murray, Henry W ^a   Illarionov, Petr A ^d   Besra, Gurdyal S ^d   Porcelli, Steven A ^b   Späth, Gerald F ^e  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD1d antigen; Glycoconjugates; Natural immunity; Trypanosomalidae

Indexed keywords

CD1D ANTIGEN; GAMMA INTERFERON; GLYCOCONJUGATE; GLYCOLIPID; INTERLEUKIN 12; LIPOPHOSPHOGLYCAN; PHOSPHATIDYLINOSITIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ANTIGEN PRESENTATION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOGENICITY; LEISHMANIA DONOVANI; LEISHMANIASIS; LIVER; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; WILD TYPE;

ANIMALS; ANTIGENS, CD1; CELL SEPARATION; DENDRITIC CELLS; DNA PRIMERS; FEMALE; FLOW CYTOMETRY; GLYCOSPHINGOLIPIDS; INTERFERON TYPE II; KILLER CELLS, NATURAL; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LIVER; LYMPHOCYTE ACTIVATION; MICE; MICE, MUTANT STRAINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 5444259450     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20040704     Document Type: Article

References (52)

1. Ashfrord, R., P. Desjeux, and P. Raadt. 1996. Estimation of population at risk of infection and number of cases of Leishmaniasis. Parasitol. Today. 8:104-105.
2. Turco, S.J., and A. Descoteaux. 1992. The lipophosphoglycan of Leishmania parasites. Annu. Rev. Microbiol. 46:65-94.
3. Späth, G.F., L. Epstein, B. Leader, S.M. Singer, H.A. Avila, S.J. Turco, and S.M. Beverley. 2000. Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. Proc. Natl. Acad. Sci. USA. 97:9258-9263.
4. Späth, G.F., L.A. Garraway, S.J. Turco, and S.M. Beverley. 2003. The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts. Proc. Natl. Acad. Sci. USA. 100:9536-9541.
5. Chan, J., T. Fujiwara, P. Brennan, M. McNeil, S.J. Turco, J.C. Sibille, M. Snapper, P. Aisen, and B.R. Bloom. 1989. Microbial glycolipids: possible virulence factors that scavenge oxygen radicals. Proc. Natl. Acad. Sci. USA. 86:2453-2457.
6. Desjardins, M., and A. Descoteaux. 1997. Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J. Exp. Med. 185:2061-2068.
7. Porcelli, S.A., and M.B. Brenner. 1997. Antigen presentation: mixing oil and water. Curr. Biol. 7:R508-R511.
8. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al. 1997. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science. 278:1626-1629.
9. Bendelac, A., M.N. Rivera, S.H. Park, and J.H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535-562.
10. Behar, S.M., and S. Cardell. 2000. Diverse CD1d-restricted T cells: diverse phenotypes, and diverse functions. Semin. Immunol. 12:551-560.
11. Wilson, S.B., and T.L. Delovitch. 2003. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Nat. Rev. Immunol. 3:211-222.
12. Kakimi, K., L.G. Guidotti, Y. Koezuka, and F.V. Chisari. 2000. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192:921-930.
13. van Dommelen, S.L., H.A. Tabarias, M.J. Smyth, and M.A. Degli-Esposti. 2003. Activation of natural killer (NK) T cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells. J. Virol. 77:1877-1884.
14. Chackerian, A., J. Alt, V. Perera, and S.M. Behar. 2002. Activation of NKT cells protects mice from tuberculosis. Infect. Immun. 70:6302-6309.
15. Gonzalez-Aseguinolaza, G., C. de Oliveira, M. Tomaska, S. Hong, O. Bruna-Romero, T. Nakayama, M. Taniguchi, A. Bendelac, L. Van Kaer, Y. Koezuka, and M. Tsuji. 2000. alpha-galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. Proc. Natl. Acad. Sci. USA. 97:8461-8466.
16. Duthie, M.S., and S.J. Kahn. 2002. Treatment with alpha- galactosylceramide before Trypanosoma cruzi infection provides protection or induces failure to thrive. J. Immunol. 168:5778-5785.
17. Skold, M., and S.M. Behar. 2003. Role of CD1d-restricted NKT cells in microbial immunity. Infect. Immun. 71:5447-5455.
18. Procopio, D.O., I.C. Almeida, A.C. Torrecilhas, J.E. Cardoso, L. Teyton, L.R. Travassos, A. Bendelac, and R.T. Gazzinelli. 2002. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway. J. Immunol. 169: 3926-3933.
19. Benlagha, K., A. Weiss, A. Beavis, L. Teyton, and A. Bendelac. 2000. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191:1895-1903.
20. Burdin, N., L. Brossay, Y. Koezuka, S.T. Smiley, M.J. Grusby, M. Gui, M. Taniguchi, K. Hayakawa, and M. Kronenberg. 1998. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes. J. Immunol. 161:3271-3281.
21. Joyce, S., A.S. Woods, J.W. Yewdell, J.R. Bennink, A.D. De Silva, A. Boesteanu, S.P. Balk, R.J. Cotter, and R.R. Brutkiewicz. 1998. Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science. 279:1541-1544.
22. Overath, P., and D. Harbecke. 1993. Course of Leishmania infection in beta 2-microglobulin-deficient mice. Immunol. Lett. 37:13-17.
23. Wang, Z.E., S.L. Reiner, F. Hatam, F.P. Heinzel, J. Bouvier, C.W. Turck, and R.M. Locksley. 1993. Targeted activation of CD8 cells and infection of beta 2-microglobulin-deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis. J. Immunol. 151:2077-2086.
24. Ishikawa, H., H. Hisaeda, M. Taniguchi, T. Nakayama, T. Sakai, Y. Maekawa, Y. Nakano, M. Zhang, T. Zhang, M. Nishitani, et al. 2000. CD4(+) v(alpha)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Int. Immunol. 12:1267-1274.
25. Shakarian, A.M., S.L. Ellis, D.J. Mallinson, R.W. Olafson, and D.M. Dwyer. 1997. Two tandemly arrayed genes encode the (histidine) secretory acid phosphatases of Leishmania donovani. Gene. 196:127-137.
26. Kapler, G.M., C.M. Coburn, and S.M. Beverley. 1990. Stable transfection of the human parasite Leishmania major delineates a 30-kilobase region sufficient for extrachromosomal replication and expression. Mol. Cell. Biol. 10:1084-1094.
27. Murray, H.W. 1997. Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis. J. Infect. Dis. 175:1477-1479.
28. Roark, J.H., S.H. Park, J. Jayawardena, U. Kavita, M. Shannon, and A. Bendelac. 1998. CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J. Immunol. 160:3121-3127.
29. Murray, H.W. 2001. Tissue granuloma structure-function in experimental visceral leishmaniasis. Int. J. Exp. Pathol. 82: 249-267.
30. Kobayashi, E., K. Motoki, T. Uchida, H. Fukushima, and Y. Koezuka. 1995. KRN7000, a novel immunomodulator, and its antitumor activities. Oncol. Res. 7:529-534.
31. Orlandi, P.A., Jr., and S.J. Turco. 1987. Structure of the lipid moiety of the Leishmania donovani lipophosphoglycan. J. Biol. Chem. 262:10384-10391.
32. McConville, M.J., T.A. Collidge, M.A. Ferguson, and P. Schneider. 1993. The glycoinositol phospholipids of Leishmania mexicana promastigotes. Evidence for the presence of three distinct pathways of glycolipid biosynthesis. J. Biol. Chem. 268:15595-15604.
33. McConville, M.J., A. Bacic, G.F. Mitchell, and E. Handman. 1987. Lipophosphoglycan of Leishmania major that vaccinates against cutaneous leishmaniasis contains an alkylglycerophosphoinositol lipid anchor. Proc. Natl. Acad. Sci. USA. 84:8941-8945.
34. Soares, R.P., M.E. Macedo, C. Ropert, N.F. Gontijo, I.C. Almeida, R.T. Gazzinelli, P.F. Pimenta, and S.J. Turco. 2002. Leishmania chagasi: lipophosphoglycan characterization and binding to the midgut of the sand fly vector Lutzomyia longipalpis. Mol. Biochem. Parasitol. 121:213-224.
35. Matsuda, J.L., O.V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C.R. Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192:741-754.
36. Stockinger, B., T. Zal, A. Zal, and D. Gray. 1996. B cells solicit their own help from T cells. J. Exp. Med. 183:891-899.
37. Naidenko, O.V., J.K. Maher, W.A. Ernst, T. Sakai, R.L. Modlin, and M. Kronenberg. 1999. Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules. J. Exp. Med. 190:1069-1080.
38. Murray, H.W., and J. Hariprashad. 1995. Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. J. Exp. Med. 181: 387-391.
39. Murray, H.W. 1999. Granulomatous inflammation: host antimicrobial defense in the tissues in visceral leishmaniasis. In Inflammation: Basic Principles and Clinical Correlates. R.S. J. Gallin, D. Fearon, B. Haynes, C. Nathan, editors. Lippincott-Raven, Philadelphia, PA. pp. 977-994.
40. Quinones, M., S.K. Ahuja, P.C. Melby, L. Pate, R.L. Reddick, and S.S. Ahuja. 2000. Preformed membrane-associated stores of interleukin (IL)-12 are a previously unrecognized source of bioactive IL-12 that is mobilized within minutes of contact with an intracellular parasite. J. Exp. Med. 192:507-516.
41. Brigl, M., L. Bry, S.C. Kent, J.E. Gumperz, and M.B. Brenner. 2003. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4:1230-1237.
42. Shamshiev, A., H.J. Gober, A. Donda, Z. Mazorra, L. Mori, and G. De Libero. 2002. Presentation of the same glycolipid by different CD1 molecules. J. Exp. Med. 195:1013-1021.
43. Tolson, D.L., S.J. Turco, and T.W. Pearson. 1990. Expression of a repeating phosphorylated disaccharide lipophosphoglycan epitope on the surface of macrophages infected with Leishmania donovani. Infect. Immun. 58:3500-3507.
44. Gorak, P.M., C.R. Engwerda, and P.M. Kaye. 1998. Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. Eur. J. Immunol. 28: 687-695.
45. Engwerda, C.R., M.L. Murphy, S.E. Cotterell, S.C. Smelt, and P.M. Kaye. 1998. Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani. Eur. J. Immunol. 28:669-680.
46. Guler, M.L., J.D. Gorham, C.S. Hsieh, A.J. Mackey, R.G. Steen, W.F. Dietrich, and K.M. Murphy. 1996. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science. 271:984-987.
47. Moll, H., G.F. Mitchell, M.J. McConville, and E. Handman. 1989. Evidence of T-cell recognition in mice of a purified lipophosphoglycan from Leishmania major. Infect. Immun. 57: 3349-3356.
48. Handman, E., and G.F. Mitchell. 1985. Immunization with Leishmania receptor for macrophages protects mice against cutaneous leishmaniasis. Proc. Natl. Acad. Sci. USA. 82:5910-5914.
49. Kemp, M., T.G. Theander, E. Handman, A.S. Hey, J.A. Kurtzhals, L. Hviid, A.L. Sorensen, J.O. Were, D.K. Koech, and A. Kharazmi. 1991. Activation of human T lymphocytes by Leishmania lipophosphoglycan. Scand. J. Immunol. 33:219-224.
50. Kropf, P., M.A. Freudenberg, M. Modolell, H.P. Price, S. Herath, S. Antoniazi, C. Galanos, D.F. Smith, and I. Muller. 2004. Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major. Infect. Immun. 72:1920-1928.
51. Debus, A., J. Glasner, M. Rollinghoff, and A. Gessner. 2003. High levels of susceptibility and T helper 2 response in MyD88-deficient mice infected with Leishmania major are interleukin-4 dependent. Infect. Immun. 71:7215-7218.
52. Wu, D.Y., N.H. Segal, S. Sidobre, M. Kronenberg, and P.B. Chapman. 2003. Cross-presentation of disialoganglioside GD3 to natural killer T cells. J. Exp. Med. 198:173-181.